RaySearch Laboratories AB (publ) (RAY-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, RaySearch Laboratories AB (publ) (RAY-B) has a cash flow conversion efficiency ratio of 0.112x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr116.90 Million ≈ $12.58 Million USD) by net assets (Skr1.04 Billion ≈ $112.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See RaySearch Laboratories AB (publ) (RAY-B) liquidity interval to measure how many days the company can operate on defensive assets alone.
RaySearch Laboratories AB (publ) - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how RaySearch Laboratories AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
RaySearch Laboratories AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of RaySearch Laboratories AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chongqing Gangjiu Co Ltd
SHG:600279
|
0.018x |
|
Steel Partners Holdings LP
NYSE:SPLP
|
-0.004x |
|
AFYA LTD. CL.A DL-00005
F:1AY
|
0.052x |
|
Ducgiang Chemicals & Detergent Powder Joint Co
VN:DGC
|
-0.069x |
|
YIT Oyj
HE:YIT
|
-0.034x |
|
Vercom SA
WAR:VRC
|
0.066x |
|
CK Power Public Company Limited
BK:CKP-R
|
0.022x |
|
Troax Group AB
ST:TROAX
|
0.025x |
Annual Cash Flow Conversion Efficiency for RaySearch Laboratories AB (publ) (2003–2025)
The table below shows the annual cash flow conversion efficiency of RaySearch Laboratories AB (publ) from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see RAY-B market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr985.30 Million ≈ $106.03 Million |
Skr387.00 Million ≈ $41.65 Million |
0.393x | -29.03% |
| 2024-12-31 | Skr876.71 Million ≈ $94.35 Million |
Skr485.23 Million ≈ $52.22 Million |
0.553x | -10.75% |
| 2023-12-31 | Skr735.23 Million ≈ $79.12 Million |
Skr455.93 Million ≈ $49.07 Million |
0.620x | +14.22% |
| 2022-12-31 | Skr657.16 Million ≈ $70.72 Million |
Skr356.78 Million ≈ $38.39 Million |
0.543x | +48.01% |
| 2021-12-31 | Skr649.28 Million ≈ $69.87 Million |
Skr238.16 Million ≈ $25.63 Million |
0.367x | -23.17% |
| 2020-12-31 | Skr694.35 Million ≈ $74.72 Million |
Skr331.51 Million ≈ $35.68 Million |
0.477x | +5.21% |
| 2019-12-31 | Skr705.47 Million ≈ $75.92 Million |
Skr320.14 Million ≈ $34.45 Million |
0.454x | +67.17% |
| 2018-12-31 | Skr657.45 Million ≈ $70.75 Million |
Skr178.47 Million ≈ $19.21 Million |
0.271x | +6.84% |
| 2017-12-31 | Skr580.42 Million ≈ $62.46 Million |
Skr147.48 Million ≈ $15.87 Million |
0.254x | -3.24% |
| 2016-12-31 | Skr460.19 Million ≈ $49.52 Million |
Skr120.85 Million ≈ $13.01 Million |
0.263x | -24.70% |
| 2015-12-31 | Skr319.52 Million ≈ $34.39 Million |
Skr111.43 Million ≈ $11.99 Million |
0.349x | +74.49% |
| 2014-12-31 | Skr251.55 Million ≈ $27.07 Million |
Skr50.27 Million ≈ $5.41 Million |
0.200x | +25.60% |
| 2013-12-31 | Skr196.60 Million ≈ $21.16 Million |
Skr31.28 Million ≈ $3.37 Million |
0.159x | -60.42% |
| 2012-12-31 | Skr217.55 Million ≈ $23.41 Million |
Skr87.45 Million ≈ $9.41 Million |
0.402x | +133.57% |
| 2011-12-31 | Skr196.70 Million ≈ $21.17 Million |
Skr33.85 Million ≈ $3.64 Million |
0.172x | -46.06% |
| 2010-12-31 | Skr196.76 Million ≈ $21.17 Million |
Skr62.78 Million ≈ $6.76 Million |
0.319x | +19.87% |
| 2009-12-31 | Skr184.86 Million ≈ $19.89 Million |
Skr49.21 Million ≈ $5.30 Million |
0.266x | +53.75% |
| 2008-12-31 | Skr150.44 Million ≈ $16.19 Million |
Skr26.05 Million ≈ $2.80 Million |
0.173x | -36.96% |
| 2007-12-31 | Skr137.85 Million ≈ $14.83 Million |
Skr37.86 Million ≈ $4.07 Million |
0.275x | +7.77% |
| 2006-12-31 | Skr118.07 Million ≈ $12.71 Million |
Skr30.09 Million ≈ $3.24 Million |
0.255x | -49.60% |
| 2005-12-31 | Skr81.85 Million ≈ $8.81 Million |
Skr41.39 Million ≈ $4.45 Million |
0.506x | +28.56% |
| 2004-12-31 | Skr32.72 Million ≈ $3.52 Million |
Skr12.87 Million ≈ $1.39 Million |
0.393x | +11.83% |
| 2003-12-31 | Skr19.82 Million ≈ $2.13 Million |
Skr6.97 Million ≈ $750.30K |
0.352x | -- |
About RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment co… Read more